Publications by authors named "Stephanie Constantinou"

Article Synopsis
  • The original publication mistakenly duplicated the EP300 blot images from two different cell lines, CAL51 and MDA-MB-231.
  • Fig. 1c originally showed the blot for CAL51 cells, but it actually displayed the image for MDA-MB-231 cells.
  • The erratum provides a new figure to correctly show the EP300 blot for CAL51 cells in Fig. 1c.
View Article and Find Full Text PDF

Mutations truncating a single copy of the tumor suppressor, BRCA2, cause cancer susceptibility. In cells bearing such heterozygous mutations, we find that a cellular metabolite and ubiquitous environmental toxin, formaldehyde, stalls and destabilizes DNA replication forks, engendering structural chromosomal aberrations. Formaldehyde selectively depletes BRCA2 via proteasomal degradation, a mechanism of toxicity that affects very few additional cellular proteins.

View Article and Find Full Text PDF

Purpose: We have previously described a novel pathway controlling drug resistance, epithelial-to-mesenchymal transition (EMT) and stemness in breast cancer cells. Upstream in the pathway, three miRs (miR-106b, miR-93 and miR-25) target EP300, a transcriptional activator of E-cadherin. Upregulation of these miRs leads to the downregulation of EP300 and E-cadherin with initiation of an EMT.

View Article and Find Full Text PDF